Business Wire

Sensor Electronic Technology Obtains Permanent Injunction Against U.S. UV LED Companies

Share

Sensor Electronic Technology, Inc. (“SETi”), a leading global innovator of deep UV LED products and technology, announced that it successfully obtained a permanent injunction in a patent infringement lawsuit against Bolb, Inc. (“Bolb”), and Quantum Egg, Inc. (“Q-Egg”).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191205005031/en/

The history of UV LED business (Graphic: Business Wire)

The history of UV LED business (Graphic: Business Wire)

The California Northern District federal court issued a permanent injunction against the sales of an accused UV LED sterilizer device, as well as any mere colorable variations, according to the parties’ stipulation. The Court will therefore prohibit the sale of similar products if they prove to be mere colorable variations of the accused products.

The asserted patents in this litigation cover fundamental UV LED technology, encompassing UV LED sterilizer structures and drivers, chip fabrication, and epitaxial layer growth.

Bolb is a UV LED company co-founded by former SETi employees, and Q-Egg was the distributor of the accused UV LED sterilizer device.

The UV LED market has expanded to a range of fields, including air and water purification devices, as well as medical and bio devices for skin care. The UV LED market value will grow up to $1.2 billion in 2022 according to a market report from LEDinside (2018).

SETi has also collaborated with South Korean UV LED company Seoul Viosys Co., Ltd. (“SVC”), resulting in the development of Violeds technology for UV LED-based disinfection, deodorization, phototherapy and curing. Violeds technology has been used by the US National Aeronautics and Space Administration (NASA) aboard the International Space Station (ISS). SETi also supplies UV LED products to America’s largest heating and cooling manufacturing brand company. This product has been recognized by customers for its high performance in sterilizing various bacteria that live inside air conditioner equipment and preventing it from spreading inside a home or office during operation.

“It is difficult to survive on a long-term basis in the UV LED industry without a strong foundation in intellectual property and technology expertise, something that SETi and SVC have gained thanks to their extensive investment in research and development,” said Chae Hon Kim, CEO of SETi.

“SETi believes in furthering a market of fair competition and investment in intellectual property. We believe that this rewards research and development, allowing entrepreneurs and small businesses to have their hard work recognized in the marketplace. We also believe in the importance of green technology. As a UV LED pioneer developing commercialized UV LED for the first time in the word, we plan to make our products available at even more competitive pricing to encourage the distribution of our green technology products in the market, thereby contributing to a clean and healthy environment,” added Kim.

Semicon Light Co, Ltd., an investor of Bolb, did sales promotion for the accused UV LED and sterilizer device UV LEDs in Japan and other countries.

About SETi

Sensor Electronic Technology, inc. (SETi), a division of Seoul Semiconductor (KOSDAQ 046890) and Seoul Viosys, is the world’s leading supplier of deep UV LEDs (emission wavelengths shorter than 340nm), as well as a broad portfolio of UV-B, and UV-C LED products and application solutions. SETi UV LEDs are certified to AS9100D with ISO 9001:2015, and the company is committed to meeting and exceeding the needs of customers and stakeholders through the highest level of quality management. To learn more, visit http://www.s-et.com/en/.

About Seoul Viosys

Seoul Viosys is the world’s first UV LED solution provider. Established in 2002 as a subsidiary of Seoul Semiconductor, the company developed EPI, FAB, and UV LEDs. In 2005, it produced UVC LEDs of 275nm, 310nm and 340nm for the first time in the world. In 2007, it achieved mass production of Deep UV LEDs for 255nm~340nm and has become the only company to produce UV LEDs of all wavelengths. Seoul Viosys has more than 6,000 patents related to UV LED technology. Its UV LED modules provide strong sterilization and disinfection (UVC), skin regeneration (UVB) and effective cultivation for horticulture. It is an eco-friendly and healthy product with no harmful chemicals unlike conventional mercury lamps. The key products have been applied to applications for water/air purification and sterilization are opening new application possibilities for horticulture, residential, commercial, water treatment facilities, health care, and even automobiles. To learn more, visit http://www.seoulviosys.com/en/.

Contact information

Sensor Electronic Technology, Inc.
Francis Jung
+1-803-647-9757 (155)
fjung@s-et.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

HighRes Biosolutions and Novo Nordisk partner to transform drug discovery in automated Lab of the Future24.1.2020 17:00:00 EETPress release

HighRes Biosolutions and Novo Nordisk A/S today announced that they will collaborate to design a state-of-the-art robotic platform for high-throughput biologics engineering and characterisation. The integration of a multi-system robotics platform with sophisticated software control architecture will enable a digital transformation and accelerated discovery for Novo Nordisk’s peptide and large molecule therapeutics research. “In order to maintain our leadership within biologics engineering we are investing in a fully automated and digital design platform. This investment is linked to our build-up in AI and advanced analytics and demonstrates Novo Nordisk’s commitment as a world leading biologics research company,” said Lars Fogh Iversen, senior vice president, Global Research Technologies, Novo Nordisk. The platform will comprise several highly automated and integrated cells for production, characterisation and functional analysis of thousands of biologic compounds every month. Its scop

Conquest Invests in 5 Greenfield Onshore Wind Parks Totalizing 43MW in the Flanders Region24.1.2020 15:37:00 EETPress release

Conquest, acting through the Conquest Sustainable Infrastructure fund, announced the transaction was closed after an exclusive agreement had been reached with ENGIE Electrabel. Conquest acquires 51% of a portfolio expected to provide 111 GWh per annum of renewable power representing the annual electricity consumption of about 32,000 Belgian homes from early 2021 onwards. The projects benefit from 15 to 20-year green certificates local remuneration schemes, and thus generate yearly secured revenues. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005221/en/ Credit: Electrabel While the energy and digital transitions continue to drive the infrastructure sector, Conquest keeps building its diversified sustainable real asset portfolio in Western European markets. The success lies in years of collaboration and long-lasting partnerships with fellow industry experts who can notably facilitate access to new growth opportunities

Fluence Expands EMEA Footprint with Horticulture Partners in Papenburg, Germany24.1.2020 14:00:00 EETPress release

Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and agriculture production, announced today it is expanding its presence in the Emsland region of Germany through partnerships with growers and other horticulture specialists operating out of Papenburg. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005109/en/ Friedrich Schulz’s 5.5 hectare farm—which grows herbs year-round in addition to lettuce, peppers and chives—utilizing VYPR 2p fixtures. (Photo: Business Wire) Given Papenburg’s decades-long history of attracting horticulture experts, Fluence’s innovative lighting solutions for horticulture are a natural fit for the region’s tomato, cucumber, leafy greens and herb growers. Forging connections with Papenburg’s horticultural leaders Elektro Evers, an engineering firm specializing in greenhouse technology, is Fluence’s exclusive systems integrator

HCL Technologies Honors Global Goodwill Champions at the 2020 World Economic Forum in Davos24.1.2020 12:47:00 EETPress release

HCL Technologies (HCL), a leading global technology company, today presented its Wave Maker Awards 2020, commemorating global goodwill champions from around the world. The award ceremony, which was held at the HCL Pavilion in Davos, celebrated organizations and individuals passionately committed to such noble causes as diversity & inclusion, education & community upliftment, environment & sustainability, and technology for change. Special guest at the awards was Australian cricket legend Glenn McGrath, who is also founder of the McGrath Foundation, which provides support for Australian women diagnosed with breast cancer and their families. The award recipients were; Lois Auta, Founder and Executive Director of Cedar Seed Foundation, which supports persons with disabilities to participate in all aspects of life; Chido Govera, Founder and Director of The Future of Hope Foundation (TFoHF), which supports marginal and vulnerable members of society through entrepreneurial and self-developme

Ipsen’s palovarotene clinical program in fibrodysplasia ossificans progressiva reaches prespecified interim analysis futility criteria24.1.2020 09:00:00 EETPress release

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the decision to pause dosing patients in the global Phase III (PVO-1A-301) study designed to evaluate the efficacy and safety of palovarotene in patients with fibrodysplasia ossificans progressiva (FOP), as well as the ongoing Phase II (PVO-1A-202/204) extension studies. In both the Phase III and Phase II extension studies, palovarotene is dosed both chronically (daily) and episodically (during flare-ups). The decision to pause dosing patients in the trial is based on results of a futility analysis reviewed by the Independent Data Monitoring Committee (IDMC) as part of the prespecified interim analysis. The results of a futility analysis indicated that the Phase III FOP trial was unlikely to meet its primary efficacy endpoint (annualized change in new HO volume as compared with Natural History Studyi) upon completion. Despite the results of the prespecified interim analysis, signals of encouraging therapeutic activity w

Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos23.1.2020 23:56:00 EETPress release

Amazentis announces the debut of Timeline, a next generation nutrition product designed to promote healthy aging, as part of the Swiss Food & Nutrition Valley in the House of Switzerland at the World Economic Forum in Davos, Switzerland. Given the increase in the aging population globally -- according to a 2019 Deutsche Bank study, there are more people on Earth older than sixty five than younger than five for the first time -- it is imperative for consumers to take proactive measures to maintain a high quality of life, for as long as they live. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200123005820/en/ (Photo: Business Wire) Timeline contains the proprietary nutrient Mitopure™, a highly pure form of Urolithin A. After a decade of rigorous research by leading scientists around the world, Mitopure has been shown to help counter age-associated cellular and muscular decline by revitalizing the mitochondria, the powerplants

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom